Financials data is unavailable for this security.
Cash flow in SEKView more
In 2023, Cereno Scientific AB increased its cash reserves by 30.01%, or 20.12m. Cash Flow from Financing totalled 106.31m or -- of revenues. In addition the company used 36.92m for operations while cash used for investing totalled 49.28m.
Cash flow per share | -0.2826 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.8998 |
---|---|
Tangible book value per share | 0.0416 |
More ▼
Balance sheet in SEKView more
Current ratio | 2.66 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.1791 |
---|---|
Total debt/total capital | 0.1519 |
More ▼